ORONSKY ARNOLD L

CIK 000120783321 companiesLA JOLLA, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001207833

Recent Transactions

50 trades

Award
KalVista Pharmaceuticals, Inc.$KALV
Director Stock Option (right to buy)
2020-10-01+7,000→ 7,000 total
Conversion
PMV Pharmaceuticals, Inc.$PMVP
Series C Preferred Stock
2020-09-29−265,203→ 0 total
Conversion
PMV Pharmaceuticals, Inc.$PMVP
Common Stock
2020-09-29+1,620,101→ 1,675,656 total
Conversion
PMV Pharmaceuticals, Inc.$PMVP
Common Stock
2020-09-29+3,488,398→ 5,164,054 total
Conversion
PMV Pharmaceuticals, Inc.$PMVP
Series A Preferred Stock
2020-09-29−3,488,398→ 0 total
Conversion
PMV Pharmaceuticals, Inc.$PMVP
Common Stock
2020-09-29+265,203→ 6,469,911 total
Conversion
PMV Pharmaceuticals, Inc.$PMVP
Series B Preferred Stock
2020-09-29−1,040,654→ 0 total
Conversion
PMV Pharmaceuticals, Inc.$PMVP
Common Stock
2020-09-29+1,040,654→ 6,204,153 total
Conversion
PMV Pharmaceuticals, Inc.$PMVP
Series A Preferred Stock
2020-09-29−3,488,398→ 0 total
Conversion
PMV Pharmaceuticals, Inc.$PMVP
Common Stock
2020-09-29+1,040,654→ 6,204,708 total
Conversion
PMV Pharmaceuticals, Inc.$PMVP
Series B Preferred Stock
2020-09-29−1,040,654→ 0 total
Conversion
PMV Pharmaceuticals, Inc.$PMVP
Series Seed Preferred Stock
2020-09-29−1,620,101→ 0 total
Conversion
PMV Pharmaceuticals, Inc.$PMVP
Common Stock
2020-09-29+3,488,398→ 5,163,499 total
Conversion
PMV Pharmaceuticals, Inc.$PMVP
Series Seed Preferred Stock
2020-09-29−1,620,101→ 0 total
Conversion
PMV Pharmaceuticals, Inc.$PMVP
Series C Preferred Stock
2020-09-29−265,203→ 0 total
Conversion
PMV Pharmaceuticals, Inc.$PMVP
Common Stock
2020-09-29+265,203→ 6,469,356 total
Conversion
PMV Pharmaceuticals, Inc.$PMVP
Common Stock
2020-09-29+1,620,101→ 1,675,101 total
Purchase
PMV Pharmaceuticals, Inc.$PMVP
Common Stock
2020-09-25$18.00/sh+55,000→ 55,000 total
Purchase
PMV Pharmaceuticals, Inc.$PMVP
Common Stock
2020-09-25$18.00/sh+55,555→ 55,555 total
Award
DYNAVAX TECHNOLOGIES CORP$DVAX
Option (Right to Buy)
2020-05-28+25,000→ 25,000 total
Disposition from Tender
AVEDRO INC
Common Stock
2019-11-21−2,742,239→ 0 total
Disposition from Tender
AVEDRO INC
Common Stock
2019-11-21−3,005→ 0 total
Conversion
Venus Concept Inc.$VERO
Common Stock
2019-11-07+301,605→ 658,657 total
Conversion
Venus Concept Inc.$VERO
Unsecured Subordinated Convertible Promissory Note
2019-11-07→ 0 total
Award
KalVista Pharmaceuticals, Inc.$KALV
Director Stock Option (Right to Buy)
2019-10-02+7,000→ 7,000 total
Purchase
Venus Concept Inc.$VERO
Unsecured Subordinated Convertible Promissory Note
2019-08-20$2000000.00/sh
Purchase
Vyome Holdings, Inc$HIND
Warrants (Right to buy)
2019-08-06+18,750→ 18,750 total
Purchase
Vyome Holdings, Inc$HIND
Common Stock
2019-08-06$4.00/sh+25,000→ 380,224 total
Award
DYNAVAX TECHNOLOGIES CORP$DVAX
Option (Right to Buy)
2019-05-30+15,000→ 15,000 total
Conversion
AVEDRO INC
Series AA Convertible Preferred Stock
2019-02-19−2,247,190→ 0 total
Conversion
AVEDRO INC
Common Stock
2019-02-19+2,247,190→ 2,348,802 total
Conversion
AVEDRO INC
Series CC Convertible Preferred Stock
2019-02-19−171,318→ 0 total
Conversion
AVEDRO INC
Series BB Convertible Preferred Stock
2019-02-19−222,119→ 0 total
Conversion
AVEDRO INC
Common Stock
2019-02-19+222,119→ 2,570,921 total
Conversion
AVEDRO INC
Common Stock
2019-02-19+171,318→ 2,742,239 total
Sale
Eiger BioPharmaceuticals, Inc.
Common Stock
2018-10-18$12.00/sh−26,465→ 1,362,327 total
Sale
Eiger BioPharmaceuticals, Inc.
Common Stock
2018-10-18$12.07/sh−210,800→ 1,388,792 total
Award
KalVista Pharmaceuticals, Inc.$KALV
Director Stock Option (Right to Buy)
2018-10-03+7,000→ 7,000 total
Purchase
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2018-09-10$17.00/sh+58,824→ 388,766 total
Purchase
Vyome Holdings, Inc$HIND
Common Stock
2018-08-23$1.82/sh+1,098,901→ 3,552,239 total
Purchase
Venus Concept Inc.$VERO
Common Stock
2018-08-09$1.50/sh+2,000,000→ 5,355,786 total
Sale
TESARO, Inc.
Common Stock
2018-08-07$26.77/sh−10,000→ 2,479 total
Exercise/Conversion
TESARO, Inc.
Common Stock
2018-08-07+10,000→ 12,479 total
Exercise/Conversion
TESARO, Inc.
Director Nonqualified Stock Option (right to buy)
2018-08-07−10,000→ 0 total
Award
DYNAVAX TECHNOLOGIES CORP$DVAX
Option (Right to Buy)
2018-05-31+15,000→ 15,000 total
Conversion
Venus Concept Inc.$VERO
Series C Preferred Stock
2017-10-16−1,647,297→ 0 total
Conversion
Venus Concept Inc.$VERO
Common Stock
2017-10-16+1,647,297→ 3,185,758 total
Conversion
Venus Concept Inc.$VERO
Common Stock
2017-10-16+1,538,461→ 1,538,461 total
Conversion
Venus Concept Inc.$VERO
Common Stock
2017-10-16$7.00/sh+170,028→ 3,355,786 total
Conversion
Venus Concept Inc.$VERO
Series B Preferred Stock
2017-10-16−1,538,461→ 0 total

Recent Filings

Address

11119 NORTH TORREY PINES ROAD

LA JOLLA, CA, 92037

View on SEC.gov